ASTARTZ

Live / Registered — Registered (as of 22 Aug 2023)

What this means for you

Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79342589
Registration number
7141339
Mark type
Word mark
Filed
25 Feb 2022
Published for opposition
06 Jun 2023
Registered
22 Aug 2023
Attorney of record
Marina Dostal

Goods and services

  • Class 001 — Chemicals: Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
  • Class 042 — Scientific and technological services: Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
  • Class 045 — Legal and security services: Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights

Owner

Prosecution history

  • 17 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 17 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 17 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 18 Jun 2024 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
  • 10 May 2024 — CORRECTION UNDER SECTION 7 - PROCESSED
  • 09 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 19 Dec 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 27 Nov 2023 — FINAL DISPOSITION NOTICE SENT TO IB
  • 27 Nov 2023 — FINAL DISPOSITION PROCESSED
  • 22 Nov 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 28 Aug 2023 — TEAS SECTION 7 REQUEST RECEIVED
  • 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER

View this trademark record on Marksy